Buprenorphine for pain management physicians: A dilemma or a therapeutic alternative?

Techniques in Regional Anesthesia and Pain Management

Volumn 9, Issue 4, 2005, Pages 216-220

  Myers, David P ^a   Augustyniak, Michael ^b   Molea, Joseph ^a,b  

^a HealthCare Connection of Tampa Inc   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Addiction; Buprenorphine; Chronic pain; Maintenance; Opioids

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CARBAMAZEPINE; ERYTHROMYCIN; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; KETOCONAZOLE; METHADONE; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; OPIATE; OXYCODONE; PERCOCET; PERCODAN; PHENOBARBITAL; PHENYTOIN; PROTEINASE INHIBITOR; TRAMADOL; TYLOX;

ANALGESIA; ANAMNESIS; BINDING AFFINITY; CHRONIC PAIN; DISEASE PREDISPOSITION; DISSOCIATION; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG WITHDRAWAL; FAMILY HISTORY; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MEIOSIS; OPIATE ADDICTION; PAIN; PHYSICIAN; PULSE RATE; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; WITHDRAWAL SYNDROME;

EID: 29244445089     PISSN: 1084208X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.trap.2005.10.007     Document Type: Article

References (44)

1. D.W. Raisch, C.L. Fye, K.D. Boardman Opioid dependence treatment, including buprenorphine/naloxone Ann Pharmacother 36 2002 312 321
2. J.O. Merrill Policy progress for physician treatment of opiate addiction J Gen Intern Med 17 2002 361 368
3. T.L. Mark, G.E. Woody, T. Juday The economic costs of heroin addiction in the United States Drug Alcohol Depend 61 2001 195 206
4. B.J. Rounsaville, T.R. Kosten Treatment for opioid dependence quality and access JAMA 283 2000 1337 1339
5. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction Effective medical treatment of opiate addiction JAMA 280 1998 1936 1943
6. R.B. Resnick Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction [letter] Ann Intern Med 138 2003 360
7. D.A. Fiellin, P.G. O'Connor Clinical practice office-based treatment of opioid-dependent patients N Engl J Med 347 2002 817 823
8. J.H. Jaffe, C. O'Keeffe From morphine clinics to buprenorphine regulating opioid agonist treatment of addiction in the United States Drug Alcohol Depend 70 2003 S3 S11
9. D.A. Fiellin, P.G. O'Connor New federal initiatives to enhance the medical treatment of opioid dependence Ann Intern Med 137 2002 688 692
10. Buprenorphine training from SAMSHA [Substance Abuse and Mental Health Services Administration Web site]. Available at http://buprenorphine.samhsa.gov. Accessed October 30, 2003.
11. W. Ling, D. Smith Buprenorphine blending practice and research J Subst Abuse Treat 23 2002 87 92
12. W.B. Pickworth, R.E. Johnson, B.A. Holicky Subjective and physiologic effects of intravenous buprenorphine in humans Clin Pharmacol Ther 53 1993 570 576
13. J. Mendelson, R.A. Upton, E.T. Everhart Bioavailability of sublingual buprenorphine J Clin Pharmacol 37 1997 31 37
14. M. Ohtani, H. Kotaki, K. Nishitateno Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine J Pharmacol Exp Ther 281 1997 428 433
15. M. Ohtani, H. Kotaki, Y. Sawada Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic- pharmacodynamic modeling J Pharmacol Exp Ther 272 1995 505 510
16. T.P. Bridge, P.J. Fudala, S. Herbert Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence Drug Alcohol Depend 70 2003 S79 S85
17. C.N. Chiang, R.L. Hawks Pharmacokinetics of the combination tablet of buprenorphine and naloxone Drug Alcohol Depend 70 2003 S39 S47
18. J. Mendelson, R.T. Jones, I. Fernandez Buprenorphine and naloxone interactions in opiate-dependent volunteers Clin Pharmacol Ther 60 1996 105 114
19. J. Mendelson, R.T. Jones, S. Welm Buprenorphine and naloxone combinations the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers Psychopharmacology (Berl) 141 1999 37 46
20. M. Auriacombe, P. Franques, J. Tignol Deaths attributable to methadone vs buprenorphine in France [letter] JAMA 285 2001 45
21. N. Lintzeris, J. Bell, G. Bammer A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal Addiction 97 2002 1395 1404
22. R.E. Johnson, T. Eissenberg, M.L. Stitzer A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence Drug Alcohol Depend 40 1995 17 25
23. W. Ling, C. Charuvastra, J.F. Collins Buprenorphine maintenance treatment of opiate dependence a multicenter, randomized clinical trial Addiction 93 1998 475 486
24. P.G. O'Connor, A.H. Oliveto, J.M. Shi A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic Am J Med 105 1998 100 105
25. R.E. Johnson, M.A. Chutuape, E.C. Strain A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence N Engl J Med 343 2000 1290 1297
26. P.J. Fudala, T.P. Bridge, S. Herbert Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone N Engl J Med 349 2003 949 958
27. The 2003 National Survey on Drug Use and Health, Department of Health and Human Services Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Available at: http://www.oas.samhsa.gov/nhsda/. Accessed September 27, 2005
28. P. Compton, V.C. Charuvastra, W. Ling Pain intolerance in opioid-maintained former opiate addicts effect of long-acting maintenance agent Drug Alcohol Depend 63 2001 139 146
29. I. Harper Temgesic abuse [letter] N Z Med J 96 1983 777
30. H.B. Rainey Abuse of buprenorphine [letter] N Z Med J 99 1986 72
31. U. Tacke Abuse of buprenorphine by intravenous injection the French connection [letter] Addiction 97 2002 1355
32. A.J. Quigley, D.E. Bredemeyer, S.S. Seow A case of buprenorphine abuse Med J Aust 140 1984 425 426
33. Y. Obadia, V. Perrin, I. Feroni Injecting misuse of buprenorphine among French drug users Addiction 96 2001 267 272
34. G.M. Robinson, P.D. Dukes, B.J. Robinson The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand Drug Alcohol Depend 33 1993 81 86
35. A. Tracqui, P. Kintz, B. Ludes Buprenorphine-related deaths among drug addicts in France a report on 20 fatalities J Anal Toxicol 22 1998 430 434
36. M. Reynaud, G. Petit, D. Potard Six deaths linked to concomitant use of buprenorphine and benzodiazepines Addiction 93 1998 1385 1392
37. M. Reynaud, A. Tracqui, G. Petit Six deaths linked to misuse of buprenorphine-benzodiazepine combinations Am J Psychiatry 155 1998 448 449
38. J.M. Gaulier, P. Marquet, E. Lacassie Fatal intoxication following self-administration of a massive dose of buprenorphine J Forensic Sci 45 2000 226 228
39. S.E. Thorn, N. Rawal, M. Wennhager Prolonged respiratory depression caused by sublingual buprenorphine Lancet 1 1988 179 180
40. J.W. Downing, N.M. Goodwin, J. Hicks The respiratory depressive effects of intravenous buprenorphine in patients in an intensive care unit S Afr Med J 55 1979 1023 1027
41. J.F. Schmidt, B. Chraemmer-Jorgensen, J.E. Pedersen Postoperative pain relief with naloxone severe respiratory depression and pain after high dose buprenorphine Anaesthesia 40 1985 583 586
42. J. Boyd, T. Randell, H. Luurila Serious overdoses involving buprenorphine in Helsinki Acta Anaesthesiol Scand 47 2003 1031 1033
43. C.D. Banks Overdosage of buprenorphine case report N Z Med J 89 1979 255 257
44. T.J. Gal Naloxone reversal of buprenorphine-induced respiratory depression Clin Pharmacol Ther 45 1989 66 71